Clinical Trial Update: A Phase III Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Seasonal Allergic Rhinitis [Phase 3]

View source ↗

Summary

This trial entry outlines a Phase III study to evaluate the efficacy and safety of PG-011 Nasal Spray in adults with moderate to severe seasonal allergic rhinit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• PG-011 Nasal Spray

Snippet

Sponsor: Prime Gene Therapeutics Co., Ltd. | Conditions: Seasonal Allergic Rhinitis, SAR | Phase 3 | Status: NOT_YET_RECRUITING